经过评估，专家小组得出结论，在建议的使用条件下，裂殖壶菌（菌株CABIO-A-2）油作为新型食品用于婴儿及较大婴儿配方食品中是安全的。部分原文报道如下：

　　Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the safety of Schizochytrium sp. (strain CABIO-A-2) oil as a novel food (NF) pursuant to Regulation (EU) 2015/2283. S.sp. is a single-cell microalga. The NF is a mixture of triglycerides in which docosahexaenoic acid (DHA) represents 38%�C44% of fatty acids. The applicant proposed to use the NF in infant formulae (IF) and follow-on formulae (FOF). The use levels proposed by the applicant were derived from Regulation (EU) 2016/127, which states the mandatory addition of DHA to IF and FOF at the level of 20�C50 mg/100 kcal. The evidence provided demo nstrated that the strain S.sp. CABIO-A-2 is phylogenetically closely related to the strain S.sp. ATCC 20888. The assessment of some already authorised S.sp. oils in the Unio n list were also ba sed on similarities with the strain ATCC 20888. The applicant provided a 90-day repeated dose toxicity study in rats with the NF. No adverse effects were observed up to the highest dose tested, i.e. 10.2 g/kg body weight (bw) per day. Taking into account the toxicity studies performed with the NF and with DHA-oils derived from strains belo nging to the genus Schizochytrium, its phylogenetical profile, the production process, the composition of the NF and the absence of marine biotoxins and viable cells in the NF, the Panel co nsiders that there are no co ncerns with regard to the toxicity of the NF. The Panel co ncludes that the NF is safe under the proposed co nditions of use.

　　 本文由食品伙伴网食品资讯中心编辑，供网友参考，有任何疑问，请联系news@www.sqrdapp.com、�/span>